Article metrics

Download PDFPDF
Clinical and molecular signature of survival and resistance to olaparib plus pegylated liposomal doxorubicin in platinum-resistant ovarian cancer: a stratified analysis from the phase II clinical trial ROLANDO, GEICO-1601

 

Online download statistics by month:

Online download statistics by month: February 2023 to November 2024

AbstractFullPdf
Feb 20238351532
Mar 202326764
Apr 202315143
May 202319854
Jun 2023474187
Jul 2023252713
Aug 20233251210
Sep 202317786
Oct 202316021
Nov 202322452
Dec 202313574
Jan 202421637
Feb 202428223
Mar 202414456
Apr 202413366
May 202413521
Jun 2024190108
Jul 202414911
Aug 202413742
Sep 202419332
Oct 20249727
Nov 20242931
Total4903130130